Fmoc-D-Lys(Dde)-OH

Fmoc-D-Lys(Dde)-OH is an Fmoc-protected, D-configured lysine amino acid derivative bearing a side-chain protected ε-amino group masked as a Dde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) hydrazone. The molecule contains the Fmoc carbamate on the α-amino functionality, a free α-carboxylic acid, and a protected ε-amino group on the lysine side chain, with the D stereochemistry indicated by the product name. In peptide synthesis workflows, the orthogonal Dde side-chain protection supports chemoselective reactions by maintaining the ε-amino group as a masked handle while the Fmoc group enables stepwise assembly of peptide intermediates on solid or solution-phase supports.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-D-Lys(Dde)-OH(CAS 333973-51-6)

CAT No: CP25762

CAS No:333973-51-6

Synonyms/Alias:Fmoc-D-Lys(Dde)-OH;333973-51-6;N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)-D-lysine;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid;MFCD01862894;(2R)-6-{[1-(4,4-DIMETHYL-2,6-DIOXOCYCLOHEXYLIDENE)ETHYL]AMINO}-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}HEXANOIC ACID;SCHEMBL19708205;(2R)-6-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid;AC5924;AKOS015911018;AS-57057;CS-0148551;Fmoc-D-Lys(Dde)-OH, >=96.0% (HPLC);doi:10.14272/ZPSRBXWVBNVFTO-RUZDIDTESA-N.1;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-[(4,4-diMe-2,6-dioxocyclohex-1-ylidene)Et]-D-lysine (Fmoc-D-Lys(Dde)-OH);95%;N6-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine;

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-lysine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C31H36N2O6
M.W/Mr.
532.6

Fmoc-D-Lys(Dde)-OH is a stereochemically defined lysine derivative bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the α-amino function and a Dde-protected side-chain ε-amino group, preserving the D-configuration at the lysine stereocenter. The molecule contains a free carboxylic acid for C-terminal coupling chemistry and two protected amines that can be selectively unmasked under orthogonal conditions. The Dde group on the ε-nitrogen is acid-labile and can be removed without disturbing the Fmoc carbamate, enabling controlled side-chain deprotection during stepwise peptide assembly. The resulting protected amino acid building block exhibits the functional-group pattern required for iterative peptide synthesis, side-chain functionalization, and downstream conversion to lysine-derived motifs used in synthetic and biochemical workflows.

1. Peptide Synthesis

Fmoc-D-Lys(Dde)-OH supports solid-phase peptide synthesis workflows where orthogonal protection of the α-amine and ε-amine is required for lysine-containing sequences. The Fmoc carbamate enables base-mediated N-terminal deprotection to expose the α-amino group for peptide coupling, while the Dde-protected ε-amino remains masked to prevent premature side-chain reactions. The free carboxylic acid participates in standard peptide coupling chemistry to form amide bonds with incoming amino acid building blocks, including D-amino acid incorporation for stereochemically defined analogs. The protected lysine side chain can be revealed later to enable selective branching, crosslinking, or attachment of functional handles, aligning with peptide science and peptidomimetic construction strategies.

2. Side-Chain Functionalization

Fmoc-D-Lys(Dde)-OH serves as a controlled platform for ε-amino side-chain modification after orthogonal deprotection of the Dde group. The lysine ε-nitrogen, once liberated, can undergo nucleophilic derivatization to introduce amide, urea, carbamate, sulfonamide, or other nitrogen-containing linkages that expand chemical diversity in peptide analogs. The presence of the Fmoc-protected α-amino functionality during earlier steps helps maintain chemoselectivity by reducing undesired side reactions at the backbone during synthesis. Downstream, lysine side-chain functionalization can be used to generate conjugation-ready intermediates for labeled peptides, immobilized biomolecule constructs, or structure-defined scaffolds used in chemical biology and synthetic methodology development.

3. Bioconjugation Chemistry

Fmoc-D-Lys(Dde)-OH is applicable to bioconjugation and biomolecule modification workflows that require site-defined lysine chemistry with stereochemical control. The D-configured lysine stereocenter can be incorporated into peptide conjugates to produce defined stereochemical environments that may influence binding or stability in biochemical assays without altering the orthogonal protection logic. The Dde-protected ε-amino group supports a staged conjugation approach where side-chain exposure can be timed relative to peptide assembly, enabling selective attachment of tags, affinity handles, or reactive moieties. The carboxylic acid and protected amines facilitate construction of conjugate precursors that can be further transformed into amide-linked or amine-reactive derivatives for analytical research, chemical biology studies, and applied biomolecule labeling.

4. Pharmaceutical Intermediate Preparation

Fmoc-D-Lys(Dde)-OH functions as a process-relevant amino acid intermediate for manufacturing peptide-based building blocks used in pharmaceutical intermediate supply chains. The Fmoc-protected α-amino group and Dde-protected ε-amino group reflect established orthogonal protection strategies that can be integrated into scalable peptide synthesis routes requiring controlled deprotection sequences. The free carboxylic acid supports conversion into activated coupling forms or direct coupling steps in downstream manufacturing of protected peptide fragments. Lysine stereochemical definition and side-chain masking enable reproducible construction of lysine-containing intermediates used for fine chemical synthesis and industrial production of peptide analogs, including peptidomimetics and other nitrogen-rich molecular scaffolds.

5. Analytical Research Standards

Fmoc-D-Lys(Dde)-OH can be employed in analytical research settings as a defined protected lysine reference material for method development and characterization of peptide intermediates. The combination of Fmoc and Dde protection provides diagnostic fragmentation and chromatographic behavior that can support LC-MS and MS/MS method tuning for protected amino acid and partially deprotected peptide species. The D-configuration and intact protecting groups enable consistent comparison across synthesis batches and can aid in monitoring deprotection events, coupling completeness, and side-chain unmasking during peptide assembly. The compound's well-defined functional-group pattern makes it suitable for generating calibration materials or structural controls used in peptide chemistry characterization, impurity profiling, and analytical verification workflows.

Size
1 g;5 g;25 g;
InChI
InChI=1S/C31H36N2O6/c1-19(28-26(34)16-31(2,3)17-27(28)35)32-15-9-8-14-25(29(36)37)33-30(38)39-18-24-22-12-6-4-10-20(22)21-11-5-7-13-23(21)24/h4-7,10-13,24-25,34H,8-9,14-18H2,1-3H3,(H,33,38)(H,36,37)/t25-/m1/s1
InChI Key
AOHSSQNORWQENF-RUZDIDTESA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Modification ServicesEpitope Mapping ServicesPeptide CDMOPeptide Synthesis ServicesPeptide Analysis ServicesCustom Conjugation ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers